-+ 0.00%
-+ 0.00%
-+ 0.00%

HELUS PHARMA - TOPLINE DATA READOUT FOR APPROACH PHASE 3 TRIAL EXPECTED IN Q4 2026

Reuters·06/24/2026 10:00:00

Please log in to view news